Valuation: Berkley Renewables Inc.

Market Cap 364K 320K 295K 276K 517K 34.36M 528K 3.54M 1.37M 16.96M 1.37M 1.34M 58.93M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.5M 4.15M 3.88M 7.27M 483M 7.43M 49.85M 19.3M 239M 19.25M 18.83M 829M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 2002-06-19
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 2006-08-16
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
-0.42%-1.65%+19.06%+5.47% 130B
-0.30%-3.33%+30.16%+59.26% 82.37B
-0.74%+2.02%+10.67%+24.13% 71.15B
-1.45%-1.96%+30.33%+43.47% 51.35B
-2.38%-3.53%+17.85%-10.84% 50.94B
-0.92%+0.21%+31.37%-10.48% 49.13B
+0.60%-1.01%+88.07%+66.29% 46.1B
+0.80%-3.39%+15.21%-18.05% 36.08B
+2.03%+3.90%-9.50%+34.51% 32.31B
Average -0.02%-1.04%+25.91%+21.53% 54.91B
Weighted average by Cap. -0.22%-1.11%+25.54%+21.84%

Financials

2016 2017
Net sales 1.03M 908K 837K 784K 1.47M 97.51M 1.5M 10.06M 3.89M 48.13M 3.88M 3.8M 167M 1.72M 1.52M 1.4M 1.31M 2.45M 163M 2.5M 16.77M 6.5M 80.28M 6.48M 6.33M 279M
Net income 173K 152K 140K 131K 245K 16.29M 250K 1.68M 650K 8.04M 649K 634K 27.93M -631K -554K -510K -478K -895K -59.46M -914K -6.13M -2.37M -29.35M -2.37M -2.32M -102M
Net Debt 2.92M 2.56M 2.36M 2.21M 4.14M 275M 4.23M 28.37M 10.99M 136M 10.95M 10.71M 472M 4.76M 4.18M 3.85M 3.61M 6.76M 449M 6.9M 46.3M 17.93M 222M 17.88M 17.49M 770M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-